Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Jul 24, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$13.1B
sum of reported positions
Reported positions
396
Changes vs prior quarter
290
18 new · 10 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 299 measured positions in 8 quarters, the typical new or larger position finished −3.9 pts against the S&P 500 and 38% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $12.2B | $13.1B |
| Positions | 388 | 396 |
| Biggest line | — | Apple 3% |
| 742K |
| $262M |
| 2.0% |
| 1.26M | $253M | 1.9% |
| 727K | $238M | 1.8% |
| 231K | $167M | 1.3% |
| 1.85M | $166M | 1.3% |
| 316K | $165M | 1.3% |
| 1.3M | $163M | 1.2% |
| 467K | $160M | 1.2% |
| 581K | $148M | 1.1% |
| 427K | $145M | 1.1% |
| 369K | $144M | 1.1% |
| 737K | $137M | 1.0% |
| 298K | $136M | 1.0% |
| 985K | $135M | 1.0% |
| 1.15M | $135M | 1.0% |
| 1.57M | $124M | 0.9% |
| 2.11M | $122M | 0.9% |
| 732K | $113M | 0.9% |
| 370K | $112M | 0.9% |
| 729K | $108M | 0.8% |
| 84K | $108M | 0.8% |
| 443K | $107M | 0.8% |
STATE STREET SPDR S&P 500 ETF
6,328 → 6,637 shares (+5%)
VANGUARD FTSE DEVELOPED ETF
53K → 60K shares (+12%)
Eli Lilly (LLY)
3,181 → 3,295 shares (+4%)
CME Group (CME)
15K → 17K shares (+15%)
INVESCO EXCHANGE TRADED FD TR
8,604 → 12K shares (+37%)
ISHARES TR RUSSELL MIDCAP
20K → 22K shares (+13%)
ASML Holding (ASML)
655 → 1,189 shares (+82%)
ISHARES CORE S&P SMALLCAP ETF
8,390 → 15K shares (+83%)
VANGUARD GROWTH ETF
3,206 → 19K shares (+500%)
Brookfield (BN)
9,352 → 28K shares (+201%)
Xylem Inc. (XYL)
7,522 → 7,732 shares (+3%)
INVESCO QQQ ETF
909 → 1,013 shares (+11%)
Carlisle Companies (CSL)
1,200 → 1,813 shares (+51%)
VANGUARD INFO TECH ETF
515 → 4,120 shares (+700%)
Unilever (UL)
7,949 → 8,054 shares (+1%)
VANGUARD S/T CORP BOND ETF
5,062 → 6,087 shares (+20%)
ISHARES S&P MIDCAP 400
5,490 → 5,754 shares (+5%)
ISHARES RUSSELL 1000 GROWTH FD
575 → 2,618 shares (+355%)
VANGUARD I/T CORPORATE BOND ET
2,697 → 3,512 shares (+30%)
